Boston Scientific
|
|
FDA Failures Continue to Put Patients at RiskApril 5th, 20125 Apr – In 1957, the Upjohn Company launched the antibiotic Panalba. The drug was administered to thousands of Americans for more than a decade. By 1968, Panalba sales totaled $18 million. After years of complaints related to the drug, FDA Commissioner Herbert Ley Jr., reported that (more…) |